EW Income Statement
Edwards Lifesciences Corp - Revenue, Expenses & Profit Analysis
Stock Price
$86.47
Market Cap
$50.77B
P/E Ratio
47.8
EPS (TTM)
$1.81
Most Recent Quarter
Period: 2024-12-31(2024-12-31)
Revenue
Total sales from operations
$1.39B
+2.3% YoY
Net Income
Bottom line profit
$385.60M
Margin: 0.2%
Earnings Per Share (Diluted)
Net income per share
$0.65
Profitability Metrics
Gross Margin
78.0%
Operating Margin
0.2%
Net Margin
0.2%
Return on Equity
0.1%
Historical Income Statements
| Period | Revenue | Gross Profit | Operating Income | Net Income | EPS |
|---|---|---|---|---|---|
| 2024-12-31 | $1.39B | - | - | $385.60M | $0.65 |
| 2024-09-30 | $1.35B | - | - | $3.07B | $5.13 |
| 2024-06-30 | $1.37B | - | - | $366.30M | $0.61 |
| 2024-03-31 | $1.33B | - | - | $351.90M | $0.58 |
| 2023-12-31 | $1.27B | - | - | $369.90M | $0.61 |
View Complete Financial Analysis
Full income statements, balance sheets, cash flows, and AI-powered insights
Open Full AnalysisFrequently Asked Questions
What is EW's revenue?
EW's most recent quarterly revenue was $1.39B, representing a growth of 2.3% year-over-year.
Is EW profitable?
EW reported a profit of $385.60M in the most recent quarter. The net profit margin is 0.2%.
What is EW's operating income?
Operating income data is available in the income statement.
What is EW's earnings per share (EPS)?
EW reported diluted earnings per share of $0.65 in the most recent quarter.
What is EW's gross profit margin?
EW has a gross profit margin of 78.0%, indicating the profitability of core operations before operating expenses.